Clinical Trials Logo
  1. Home
  2. Other
  3. NCT04930952

Complications of Ethanol-amine Oleate Intralesional Sclerotherapy

Venous Malformation Clinical Trial

Official title:
Complications of Ethanol-amine Oleate Intralesional Sclerotherapy Injections of Maxillofacial Venous Malformations in Pediatric Patients

Clinical Trial Summary

The aim of this study is to clarify complications of Ethanolamine Oleate intralesional injections of maxillofacial venous formations in pediatric patients

Clinical Trial Description

Maxillofacial Venous malformations cause many functional and esthetic complications in children, intralesional sclerotherapy is the best choice of treatment; and Ethanol-amine Oleate has been the most commonly used sclerosing agent. The aim of this study is to clarify complications of Ethanolamine Oleate intralesional injections of maxillofacial venous formations ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04930952
Study type Observational [Patient Registry]
Source Suez Canal University
Contact
Status Completed
Phase
Start date February 28, 2019
Completion date March 3, 2021
View Details
See also
  Status Clinical Trial Phase
Terminated NCT04409145 - First in Human Trial of Topical VT30 in Pts With Venous/Lymphatic Malformations Assoc With PIK3CA or TEK Gene Mutations Phase 1/Phase 2
Completed NCT05586919 - Treatment of Venous Malformation N/A
Completed NCT04637997 - Influence of Flat-knitted Compression Stockings Class I and II on Venous Malformations N/A
Recruiting NCT03767660 - Efficacy of Rapamycin (Sirolimus) in the Treatment of BRBNS, Hereditary or Sporadic Venous Malformation Phase 4
Completed NCT04486599 - Electromagnetic Navigation During Ultrasound Guided Foam Sclerotherapy for Venous Malformations N/A
Recruiting NCT04861064 - Weekly Sirolimus Therapy Phase 2
Recruiting NCT05563831 - National Evaluation of Patients With PIK3CA-Related Overgrowth Spectrum (PROS)
Recruiting NCT04258046 - Trametinib in the Treatment of Complicated Extracranial Arterial Venous Malformation Phase 2
Active, not recruiting NCT01347294 - Compare Two Different Sclerosing Agents in the Treatment of Venous Malformations Phase 4
Completed NCT04836884 - Vascular Anomaly Pathology and Genomics Biopsy Study N/A
Not yet recruiting NCT05983159 - A Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations Phase 2